These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


186 related items for PubMed ID: 4302194

  • 1. Recent developments in pathophysiologic studies of the renin-angiotensin system.
    Haber E.
    N Engl J Med; 1969 Jan 16; 280(3):148-55. PubMed ID: 4302194
    [No Abstract] [Full Text] [Related]

  • 2. [Diagnosis and therapy of arterial hypertension. Significance of the renin-angiotensin-aldosterone system in differential diagnosis and therapy].
    Nast HP, Philipp T.
    Fortschr Med; 1974 Apr 18; 92(11):447-51. PubMed ID: 4362672
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. [Renin-angiotensin-(aldosterone)-system-clinical aspects].
    Börner H.
    Z Gesamte Inn Med; 1973 Dec 15; 28(24):757-62. PubMed ID: 4360460
    [No Abstract] [Full Text] [Related]

  • 5. Significance of renin and angiotensin in hypertension.
    Brown JJ, Fraser R, Leckie B, Lever AF, Morton JJ, Padfield PL, Semple PF, Robertson JI.
    Cardiovasc Clin; 1978 Dec 15; 9(1):55-89. PubMed ID: 352522
    [No Abstract] [Full Text] [Related]

  • 6. Studies of plasma renin activity in patients with hypertension.
    Kokot F, Kuska J, Czekala Z, Kiecoń I.
    Pol Med J; 1968 Dec 15; 7(6):1319-27. PubMed ID: 4305122
    [No Abstract] [Full Text] [Related]

  • 7. Endocrine causes of hypertension.
    Batsakis JG.
    J Ky Med Assoc; 1973 Mar 15; 71(3):159-68 passim. PubMed ID: 4348559
    [No Abstract] [Full Text] [Related]

  • 8. The effects of the angiotensin II antagonist saralasin on blood pressure and plasma aldosterone in man in relation to the prevailing plasma angiotensin II concentration.
    Brown JJ, Brown WC, Fraser R, Lever AF, Morton JJ, Robertson JI, Rosei EA, Trust PM.
    Prog Biochem Pharmacol; 1976 Mar 15; 12():230-41. PubMed ID: 1019166
    [Abstract] [Full Text] [Related]

  • 9. [Renin-angiotensin-aldosterone system in blood pressure regulation disorders].
    Kaufmann W.
    Verh Dtsch Ges Inn Med; 1968 Mar 15; 74():56-79. PubMed ID: 4306317
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Clinical physiopathology of certain forms of secondary arterial hypertension].
    Veyrat R.
    Schweiz Med Wochenschr; 1973 Nov 24; 103(47):1653-62. PubMed ID: 4356590
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Effect of corticotropin on aldosterone excretion and plasma renin in normal subjects, in essential hypertension and in primary aldosteronism.
    Newton MA, Laragh JH.
    J Clin Endocrinol Metab; 1968 Jul 24; 28(7):1006-13. PubMed ID: 4298942
    [No Abstract] [Full Text] [Related]

  • 16. The pathophysiology of renin.
    Berman LB, Vertes V.
    Clin Symp; 1973 Jul 24; 25(5):1-35. PubMed ID: 4358471
    [No Abstract] [Full Text] [Related]

  • 17. The physiology of blood pressure regulation--normal and abnormal.
    Hiner LB, Gruskin AB.
    Pediatr Ann; 1977 Jun 24; 6(6):373-83. PubMed ID: 865908
    [No Abstract] [Full Text] [Related]

  • 18. [Renin and aldosterone in human arterial hypertension (excluding Conn's syndrome)].
    Veyrat R, Genest J, Tremblay G, Boucher R, de Champlain J.
    Pathol Biol; 1965 Nov 24; 13(21):1086-93. PubMed ID: 4299263
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 10.